Floatz logo

Medroxyprogesterone acetate

Cardiovascular Disorder

Peking Union Medical College HospitalPhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
89/ 100

Competitive context

60 Active assets in the Cardiovascular Disorder cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
AstraZeneca
Phase 4BBB
Lipitor
Duke University
Phase 4BBB
Liraglutide
University of Sao Paulo General Hospital
Phase 4BBB
Rosuvastatin
Nanjing First Hospital, Nanjing Medical University
Phase 4BBB
SIMVASTATIN
McMaster University
Phase 4BBB

View all 50 →

Same molecule, other indications

Medroxyprogesterone acetate is also rated in:

osteoporosisDormant
BBB
Indicative ·
72 / 100
View asset →
sickle cell diseaseDormant
BB
Indicative ·
65 / 100
View asset →
Hot FlashesDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →